Evidence map›Paper›PMID 12829845›Full record

ArticleJournal of virology2003

Multiple interactions across the surface of the gp120 core structure determine the global neutralization resistance phenotype of human immunodeficiency virus type 1.

Peter Bouma, Maria Leavitt, Peng Fei Zhang, Igor A Sidorov, Dimiter S Dimitrov, Gerald V Quinnan

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Germline-targeting immunogens.Immunological reviews · 2017
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Peter BoumaDivision of Tropical Public Health, Department of Preventive Medicine and Biometrics, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814, USA.
Maria Leavitt
Peng Fei Zhang
Igor A Sidorov
Dimiter S Dimitrov
Gerald V Quinnan
Uniformed Services University of the Health Sciences · USFrederick National Laboratory for Cancer Research · USNational Institutes of Health · US

Funding

HIV-1 gp140 Oligomers as Vaccine ImmunogensP01AI048280 · NIAID · The Johns Hopkins University · PI QUINNAN, GERALD V. · 2001 to 2003
$4.6M
NEUTRALIZATION RESISTANCE OF HIV1R01AI037438 · NIAID · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI QUINNAN, GERALD V. · 1995 to 2005
$1.3M
NEUTRALIZATION RESISTANCE OF HIV-1R21AI037438 · NIAID · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI QUINNAN, GERALD V. · 1999 to 1999
–
NIAID NIH HHS AI 37438NIAID NIH HHS AI 48280NIAID NIH HHS P01 AI048280NIAID NIH HHS R01 AI037438NIAID NIH HHS R21 AI037438
6 · The paper itself

Abstract

Resistance to neutralization is an important characteristic of primary isolates of human immunodeficiency virus type 1 (HIV-1) that relates to the potential for successful vaccination to prevent infection and use of immunotherapeutics for treatment of established infection. In order to further elucidate mechanisms responsible for neutralization resistance, we studied the molecular mechanisms that determine the resistance of the primary virus isolate of the strain HIV-1 MN to neutralization by soluble CD4 (sCD4). As is the case for the global neutralization resistance phenotype, sCD4 resistance depended upon sequences in the amino-terminal heptad repeat region of gp41 (HR1), as well as on multiple functional interactions within the envelope complex. The functional interactions that determined the resistance included interactions between the variable loop 1 and 2 (V1/V2) region and sequences in or near the CD4 binding site (CD4bs) and with the V3 loop. Additionally, the V3 loop region was found to interact functionally with sequences in the outer domain of gp120, distant from the CD4bs and coreceptor-binding site, as well as with a residue thought to be located centrally in the coreceptor-binding site. These and previous results provide the basis for a model by which functional signals that determine the neutralization resistance, high-infectivity phenotype depend upon interactions occurring across the surface of the gp120 core structure and involving variable loop structures and gp41. This model should be useful in efforts to define epitopes that may be important for primary virus neutralization.

Indexed as

Amino Acid SequenceAmino Acid SubstitutionAntibodies, MonoclonalCD4 AntigensHIV-1HIV AntibodiesHIV Envelope Protein gp120HIV Envelope Protein gp41HumansModels, MolecularMolecular Sequence DataNeutralization TestsPeptide FragmentsRecombinant Fusion ProteinsAntibodies, MonoclonalCD4 AntigensHIV AntibodiesHIV Envelope Protein gp120HIV envelope protein gp120 (305-321)HIV Envelope Protein gp41Peptide FragmentsRecombinant Fusion Proteins

Identifiers

PMID12829845
PMCPMC161940
OpenAlexW2087354758

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.